Related Experiment Videos
Effectiveness of contrast regimens in CT detection of vascular malformations of the brain
Insights
Delayed high dose computed tomography (CT) scans offer no significant advantage for brain vascular malformations. However, these scans can be safely used for suspected blood-brain barrier lesions without missing vascular malformations.
Area of Science:
- Neuroradiology
- Medical Imaging
Background:
- Cerebral vascular malformations present diagnostic challenges.
- Computed tomography (CT) is a key imaging modality.
Purpose of the Study:
- To evaluate the utility of delayed high-dose contrast CT in diagnosing cerebral vascular malformations.
- To assess if delayed scans improve detection or introduce artifacts.
Main Methods:
- Forty-three patients with cerebral vascular malformations underwent precontrast, immediate contrast, and 1-hour delayed high-dose contrast CT.
- Image analysis focused on identifying malformations, hemorrhage, infarction, and venous angiomas.
Main Results:
- Precontrast CT scans were abnormal in 81% of patients.
- Delayed scans revealed occult arteriovenous malformations and additional hemorrhage/infarction zones.
- Venous angiomas were seen on immediate but not delayed scans.
- Large vessels surrounding malformations faded on delayed scans, reducing specificity.
Conclusions:
- Delayed high-dose contrast CT provides no significant advantage for symptomatic cerebral vascular malformations.
- These scans do not preclude the detection of vascular malformations.
- Delayed high-dose CT is safe for patients with suspected blood-brain barrier lesions.
Abstract:
Forty-three patients with cerebral vascular malformation were studied with precontrast, immediate contrast, and 1 hr delayed high dose contrast computed tomography (CT) scans. The precontrast scans were abnormal in 81% of patients. The delayed high dose scans demonstrated one angiographically occult, thrombosed arteriovenous malformation not seen on pre- or immediate contrast scans, four cases with additional zones of encapsulated hemorrhage or infarction not seen on pre- or immediate contrast CT, and two cases of venous angiomas seen on immediate contrast scans but not on delayed high dose scans. In 50% of patients, large vessels surrounding the malformation faded on the delayed dose scans which were less specific for vascular malformation than immediate contrast CT. We conclude that: (1) delayed high dose scans offer no significant advantage in patients with symptoms suggesting vascular malformation of the brain; and (2) while less specific than immediate contrast CT, these scans do not preclude detection of vascular malformations of the brain. Therefore, delayed high dose CT can be used in patients with suspected blood-brain barrier lesions without fear of missing vascular malformations.